Contact

For general enquiries, please email info@harnesstx.com.

For partnering and business development enquiries, please email bd@harnesstx.com.

For media enquiries, please contact ICR Healthcare at harnesstx@icrinc.com.

Harness is headquartered in Cambridge:

Harness Therapeutics Ltd
Minerva Building 250
Babraham Research Campus
Cambridge
CB22 3AT

Send us a message

Our programmes

Huntington's Disease

ALS and Alzheimer's

Our news

October 2025

Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture Investment

Read more

June 2025

Harness Therapeutics Publishes HTT CAG Repeat Sizing Methodology Code on GitHub

Read more

February 2025

Harness Therapeutics to Present Nanopore Sequencing Data for Detecting CAG Expansion in the Huntingtin Gene at CHDI Huntington’s Disease Therapeutics Conference

Read more

January 2025

Harness Therapeutics appoints Dr Heather Preston as Chair and secures new funding from Ono Venture Investment to accelerate delivery of transformational neurodegeneration pipeline

Read more